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Abstract: Lycium (also known as Goji berry) is used in traditional Chinese medicine (TCM) with
claimed benefits, including eye and liver protection, immune system fortification and blood glucose
control. The commercially available product comes from either the L. barbarum or L. chinense species,
with the former dominating the marketplace due to its better taste profile. The main objective of this
study was to develop a validated LC-ESI-MS/MS method to quantify multiple key bio-active analytes
in commercially available Lycium berries and to qualitatively assess these samples using a principal
component analysis (PCA). A LC-ESI-MS/MS method for the quantitation of seven analytes selected
using the Herbal Chemical Marker Ranking System (Herb MaRS) was developed. The Herb MaRS
ranking system considered bioavailability, bioactivity and physiological action of each target analyte,
its intended use and the commercial availability of an analytical standard. After method optimization
combining high resolving power with selective detection, seven analytes were quantified and the
Lycium samples were quantitatively profiled. Chromatographic spectra were also obtained using
longer run-time LC-UV and GC-MS methods in order to qualitatively assess the samples using a
principal component analysis (PCA). The result of the method validation procedure was a 15.5 min
LC-ESI-MS/MS method developed for the quantification of seven analytes in commercial Lycium
samples. Wide variation in analyte concentration was observed with the following results (analyte
range in mg/g): rutin, 16.1–49.2; narcissin, 0.37–1.65; nictoflorin, 0.26–0.78; coumaric acid, 6.84–12.2;
scopoletin, 0.33–2.61; caffeic acid, 0.08–0.32; chlorogenic acid, 1.1–9.12. The quantitative results for
the L. barbarum and L. chinense species samples indicate that they cannot be differentiated based
on the bio-actives tested. A qualitative assessment using PCA generated from un-targeted LC-UV
and GC-MS phytochemical spectra led to the same conclusion. The un-targeted quantitative and
qualitative phytochemical profiling indicates that commercial L. barbarum and L. chinense cannot be
distinguished using chemical analytical methods. Genetic fingerprinting and pharmacological testing
may be needed to ensure the efficacy of commercial Lycium in order to validate label claims.
Keywords: Lycium; Herb MaRS; LC-MS; Chemometrics; PCA
Plants 2019, 8, 604; doi:10.3390/plants8120604 www.mdpi.com/journal/plants
Plants 2019, 8, 604 2 of 17
1. Introduction
The Lycium genus comprises of approximately 75 species and is the most widely distributed
Solanaceae genera native to arid and sub-arid regions of South America, Southern Africa, Eurasia and
Australia [1]. It grows primarily in northwest China and Tibet [2]. The fruit is shade dried until the
skin shrinks then sun dried until the outer skin becomes dry and hard but with the pulp still soft.
China is the main supplier of Lycium barbarum berry products, with 95,000 tons of exports totaling $120
million in 2004 [3]. Effective marketing has led to the product being perceived as a “super food”.
Goji is the common name for the berry of L. barbarum and L. chinense, which is sold as a food
and dietary supplement. The berry is shade dried until it shrinks, then sun dried until the outer skin
hardens but with the pulp still soft. Generally, the L. chinense species is grown in southern China while
the L. barbarum is grown in the north where the plant is somewhat taller but there is not always a clear
distinction in the morphology of their fruits as there is intra-species variation. A review paper on the
subject states that “The fruits of Lycium species possess a highly similar anatomy and tissue structure
and differentiation based on morphological and histological analyses is very delicate [4].” Additionally,
the chemical composition is influenced by factors such as natural variation, growth conditions (such as
soil type and climate), time of harvest and by post-harvest treatment, including storage conditions.
While a botanically certified sample of L. barbarum fruit is commercially available, the authors are
unable to source one for the L. chinense species. While there is a broad view that these two species are
similar, they may have different applications in traditional Chinese medicine (TCM). For reasons that
are not clear, it appears that the fruit of the L. barbarum is more often used while the roots and leaves of
the L. chinense are favored. There is a study that reported that the leaf extract of L. chinense had more
polyphenols, flavonoidic compounds and caffeic acid derivatives than that from L. barbarum as well
as showing greater microbial activity. The fruits of the L. barbarum and L. chinense varieties were not
examined concurrently in this study [5]. Another study reported a difference in the phytochemical
composition of the fruit where that of the L. barbarum has a higher sugar content than L. chinense and
that soil chemistry greatly affects the concentration of sugar [6]. A study comparing the taste pattern
(using taste sensors) and betaine (an amino acid) concentration reported that the L. barbarum had
double the sugar and about 15% more betaine than the L. chinense. The samples in the study were
obtained from 15 distributors, with the variability in the concentrations being surprisingly small at
about 20% and 17% RSD (relative standard deviation) for betaine and sugar respectively [7]. There is a
view that the only reliable way to distinguish between the two species is via molecular techniques
such as random amplified polymorphic DNA analyses [8,9]. Most of the studies on the phytochemical
differences between the two Lycium species obtain their L. chinense samples directly from the geographic
region from which it is known to grow it rather than from certified botanical samples.
Un-targeted chromatographic profiling analysis has used to obtain chromatographic profiles for
L. barbarum and L. chinense samples by determining all detectable constituents without necessarily
identifying or quantifying a specific compound in a single analysis [10,11]. The more recent research
regarding Lycium has focused on either the anti-oxidant or anti-microbial aspect [5,12,13] with LC-UV
methodologies [14,15]. LC-UV (or PDA) detects substances with a chromophore (UV absorbing part of
the molecule) while GC-MS detects volatile substances. Both are useful for un-targeted analysis as
they provide rich chromatographic spectra and detect substantially different groups of substances.
Targeted analysis seeks to detect and quantify a specific number of selected chemicals and as such, is
not as spectrally rich as the two previous techniques [16].
LC-ESI-MS/MS is more suited for targeted analysis in a complex matrix due to being sensitive and
selective. When there is a greater possibly of chromatographic peak overlap and misidentification, the
MS detector can minimize this problem by providing peak identity confirmation. The MS can be set to
detect only a specific mass-to-charge ratio (m/z) and if tandem MS/MS is used, the precursor m/z can be
subjected to fragmentation by a collision gas and the product m/z’s detected with their relative ratios
compared between the standard and samples. Furthermore, analytes without a chromophore can be
detected using MS/MS.
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The main aim of this study was the development and validation of a rapid UPLC-MS
(ultra-performance liquid chromatography with mass spectrometry detection) method to determine
seven major bio-actives in L. barbarum and L. chinense. The validated method can be used for
better quality control (QC) in commercial Lycium, thereby enabling some measure of standardisation,
providing the consumer with a more consistent product [17]. A secondary objective was to examine if
Lycium species in the marketplace labelled as ‘L. barbarum’ and ‘L. chinense’ are qualitatively different in
principal component analysis (PCA) using spectra from LC-UV and GC-MS. The target analytes were
selected using the Herbal Chemical Marker Ranking System (Herb MaRS) developed at the National
Institute of Complementary Medicine (NICM) to assess the bioactivity, physiological activity and the
bioavailability of each bio-active analyte present in any herb or herbal formulation [18]. The chemical
structures of seven target bio-active analytes are shown in Table 1 and their pharmacological activities
and rankings are shown in Table 2.
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Table 2. Reported pharmacological activities of target analytes in Lycium.













Coumaric acid [33,34] Anti-hepatotoxic, anti-oxidant 3
Scopoletin [35–37] Anti-hepatotoxic, anti-oxidant 3
Caffeic acid [38–40] Anti-oxidant, anti-inflammatory,anti-hepatotoxic, hepatotropic 2
Chlorogenic acid [41,42] Hepatotropic, anti-inflammatory 2
a: Herbal Chemical Marker Ranking System (5). b: The ranking score ranges from 0 to 5, with 0 being the least and 5
being the most suitable.
2. Methods
2.1. Instrumentation
A Waters ACQUITY UPLC system (Milford, MA, USA) consisting of a binary sample manager,
a sample manager, including the column heater, detector and sample organiser coupled to a Xevo
TQ tandem-quadrupole mass spectrometer equipped with a Z-spray electrospray interface, was
used. The binary solvent manager used two individual serial flow pumps to deliver a parallel binary
gradient mixed under high pressure with built-in solvent degassing and up to four solvent select
valves. The ACQUITY system is capable of pumping mobile phase at pressures up to 15,000 psi.
Negative electrospray ionization (ESI) was performed in the multiple reaction monitoring (MRM)
mode. The loop size was 10 µL. Separation was carried out on an ACQUITY UPLC BEH C18 column
(100 mm × 2.1 mm, 1.7 µm).
The herb grinder used for processing raw samples was a M20 Universal Mill IKA®instrument
(Werke Staufen, Germany). The ultrasonic bath was a Branson 1510 from Branson Ultrasonics (Danbury,
CT, USA), and the centrifuge used was a Beckmann GP from Beckmann Coulter (Brea, CA, USA).
An Adam AFA-210LC analytical balance (Oxford, CT, USA) and a Sartorius SE-2 micro analytical
balance (Gottingen, Germany) were used to weigh the samples and analytical standards.
2.2. Reagents, Chemicals and Samples
The analytical reference standards rutin (94%), caffeic acid (99%), coumaric acid (98%), chlorogenic
acid (95%), and scopoletin (99%) were purchased from Sigma-Aldrich (St Louis, MO, USA); nictoflorin
and narcissin were of secondary grade from Phytomarker Ltd. (Tianjin, China). The primary grade
standards have purity and spectroscopic standardisation while the secondary grade standards have
purity by LC-UV only. The calibration curves were prepared with adjustment for standard purity.
UPLC grade methanol and AR grade ethyl acetate was obtained from Biolab (Clayton, VIC,
Australia). AR grade formic acid was obtained from Univar (Downers Grove, IL, USA). Phosphorus
pentoxide (used as desiccant) was from Sigma-Aldrich (St Louis, MO, USA). Air, argon, helium,
hydrogen and nitrogen were of ultra-high purity grade from Coregas (Yennora, NSW, Australia).
Purified water (>18 MΩ cm) was obtained from an Elga Purelab Prima and Purelab Ultra high purity
water system (Aubervilliers, France).
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Twelve samples of the dried raw herb berries (8 labelled as L. barbarum and 4 as L. chinense)
were obtained from local retail shops in Sydney, Australia. The authenticity of the raw material was
established by chromatographic profile comparison against a certified reference sample of L. barbarum
berry (batch number AAT15209CRB) purchased from Alkemists Pharmaceuticals (Stanton, CA, USA).
A certified reference sample of L. chinense berry was not commercially available. The certified Lycium
sample was primarily used for comparison to the commercial Lycium samples in the PCA of LC-UV
and GC-MS spectra. Analytical method validation was performed on the L. barbarum sample LB7.
2.3. Sample Extraction and LC Mobile Phase Preparation
The raw samples were dried over phosphorus pentoxide in a desiccator for one week, then ground
to pass through a ≤ 250 µm sieve before being stored in the desiccator under vacuum. To determine the
optimal extraction solvent, various aqueous methanolic solutions were investigated and the solvent
that resulted in the largest overall peak area was subsequently selected for use. The concentration of
the analytes in the unspiked samples was determined by weighing a known amount of the ground
raw herb (~1.0 g) into a 10 mL volumetric flask and extracted by sonication in 7 mL 50% aqueous
methanol for 2 × 30 min, (15 min cooling interval between sonications). After cooling, the flask was
made up to volume with the extraction solvent and mixed by vortexing. The supernatant was then
transferred to a centrifuge tube and centrifuged at 4000 rpm for 10 min. The aliquot of the supernatant
was then filtered through a 0.22 µm PVDF membrane filter into a 2 mL auto sampler vial for analysis.
The filtrate was stored at 4 ◦C if not analysed on the same day. Each sample was analysed in seven
replicates (extraction and analysis). The mobile phase program is shown in Table 3, with a flow rate of
0.2 mL/min and a run time of 15.5 min.
Table 3. Mobile phase gradient program for the LC-ESI-MS/MS method.








2.4. Preparation of Stock Calibration Solution Using Analytical Standards
Individual solutions of 5000 µg/mL of rutin, chlorogenic acid, coumaric acid were prepared by
weighing 50.0 mg of analytical standard (using a microbalance) into a 10 mL volumetric flask and
adding approximately 7 mL of methanol before sonication for 5 min or until the solid was dissolved.
The solution was then cooled before making up to volume with methanol. In a similar manner,
individual solutions containing 500 µg/mL of narcissin, nictoflorin, scopoletin and caffeic acid were
prepared from 5.0 mg of analytical standard. The solutions were stored at 4 ◦C and discarded if not
used within 2 weeks.
A mixed standard stock solution containing 1140 µg/mL rutin, 39.6 µg/mL chlorogenic acid,
89.4 µg/mL coumaric acid, 60 µg/mL narcissin, 11.6 µg/mL nictoflorin, 17.4 µg/mL scopoletin and
1.64 µg/mL caffeic acid was prepared by adding 5.7, 1.7, 3.7, 2.5, 0.50, 0.80 and 0.10, mL of the respective
individual analytical standards into a 25 mL volumetric flask and making up to volume with methanol.
This mixed standard stock solution was used as the spiking solution for analyte recovery studies and
preparation of working calibration solutions.
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The working calibration solutions were prepared by diluting 50, 150, 250, 500 and 1000 µL of the
mixed standard stock solution to 1000 µL with methanol, representing a 1/20, 1/10, 1/4, 1/2 and the
undiluted standard respectively. The linear range for each analyte is the linear calibration range for the
standards in the calibration solution. This encompasses the concentration range for each analyte of
interest in every commercially purchased Lycium sample.
2.5. Recovery Studies
To determine the analyte extraction efficiency of the method, accurately weighed 1.0 g of the
ground herb sample was transferred into 10 mL volumetric flasks and 0.5 mL of the spiking stock
solution was added for the 100% spike level. For the 50% and 200% spike levels, the amounts were
adjusted in proportion. The concentration of the mixed spiking solution was arranged such that for
the 100% spike level, the resultant peak area would be twice that of the unspiked sample. Seven
replicates were used for each spike level to obtain a total of twenty-one injections for the three spike
levels. The spiking solvent was evaporated overnight in a fume hood.
2.6. LC-ESI-MS/MS Conditions
The ESI source conditions were set with nitrogen desolvation gas at 800 L/h heated to 350 ◦C and
argon used as the collision induced dissociation gas at 0.15 mL/min. The collision gas pressure was
maintained at 4.3 × 10−6 bar in the collision cell. The scan time was set at 0.005 s, the extractor cone
was set at 3V and cone gas flow set at 20 L/h. The source block temperature was set at 150 ◦C, the
capillary voltage in the negative (−) ESI mode was 2.40 kV. Manual tuning for optimal cone voltage
and collision energy was performed using the built-in instrument fluidics system. Dwell times for
the multiple reaction monitoring (MRM) channels were automatically calculated by the software, the
required data points were selected for peak determination. The inter-channel and inter-scan delay
time was set to 3 milli-seconds.
System operation and data acquisition were controlled using the Waters Mass Lynx 4.1 software.
Two or if possible three MRM products (or transition m/z’s) were chosen for each target analyte, with
the most abundant product used as the quantifier and the others used as the qualifiers. Two product
ions with matching intensities between the standard and sample peaks meet the analyte identity
confirmation standard set by the European Commission Directorate for Agriculture guidelines [43].
The ESI polarity, precursor and product ions were monitored, and the argon collision voltages required
to achieve the transitions and the dwell times used are summarised in Table 4.
Table 4. LC-ESI-MS/MS monitoring conditions.
Analyte ESIPolarity Precursor m/z Product m/z
Respective
Voltages (V) Dwell Time (s)
Rutin - [M-H]− = 609 255, 271, 300 50, 62, 40 0.016
Narcissin - [M-H]− = 623 299, 315 48, 30 0.017
Nictoflorin - [M-H]− = 593 255, 284 54, 34 0.017
Coumaric acid - [M-H]− = 164 93, 120 12, 26 0.016
Scopoletin - [M-H]− = 191 103, 176 24, 16 0.016
Caffeic acid * - [M-H]− = 179 135 15 0.195
Chlorogenic acid - [M-H]− = 353 93, 191 50, 50 0.095
*: Only one product m/z ion was observed for caffeic acid.
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2.7. LC-UV and GC-MS Methods Used to Obtain Spectra for PCA Analysis
The LC-UV spectral profiles used to study the phytochemical variability of the L. barbarum and L.
chinense samples using principal component analysis (PCA) were generated. Analysis was performed
using a Varian (California, USA) Prostar solvent delivery system comprising of 2 × 210 single pumps
equipped with a 335-photodiode array detector (PDA), a ‘9×0 mm’ analytic flow cell (Varian Inc.,
Australia), column valve module 500 and 430 auto sampler injector. Solvents were degassed using a
model AF DG2 in-line degasser (Waters, USA). The system was controlled using Varian Star Workstation
version 6.20. A security C18 guard column (3 × 4.6 mm, 5 µm) was used with a Phenomenex Luna
C18 column (150 × 4.6 mm, 5 µm) (Torrance, CA, USA) analytical column. The injection volume was
10 µL and column temperature 30 ◦C. The PDA was set to acquire data from 200–400 nm and the
chromatograms visualized at 280 nm. The mobile phase was acetonitrile (A) and water containing
0.1% formic acid (B) with a flow rate of 1 mL/min. Each sample was injected in triplicate and the run
time 100 min. Initially 95% mobile phase B was held for 5 min. A slow gradient was applied to 55 min
where the mobile phase B was 90%. Another gradient was applied until 80 min where mobile phase B
was 80%. Mobile phase B was changed to 5% at 81 min and then held at 5% until 90 min. Then mobile
phase B was set to 95% at 91 min and held to 100 min as the wash phase.
GC-MS was also used to obtain chromatographic spectral profiles for PCA analysis, and the
method used is described as follows. The injection volume programmed into the auto sampler was
1 µL, pre-cleaning the syringe with ethanol once and the sample five times before each injection.
The syringe was rinsed with ethanol five times after each injection. The injector temperature was set
at 200 ◦C using a split ratio of 10:1. The column pressure was programmed to maintain a constant
flow of 1.5 mL/min. The initial oven temperature was 50 ◦C held for 1 min, then increased at a rate of
10 ◦C/min to 300 ◦C and held for 3 min. The oven temperature was then increased to 350 ◦C for 2 min
after each run to clean the column. The MS transfer line was maintained at 250 ◦C, the EI source at
230 ◦C and the quadrupole at 150 ◦C. The helium carrier gas was set to flow at 1.0 mL/min. The MS
scan range was 40–500 m/z. Each run was 140 min and analysis performed in triplicate.
2.8. PCA Analysis
The LC-UV and GC-MS spectral data sets of the Lycium samples were subjected to principal
component analysis (PCA) which can help identify components that explain the variability in a data
set. LC-UV and GC-MS spectra were preferred over LC-ESI-MS/MS data for PCA since they are more
spectrally rich and provide wider context information regarding qualitative information. In the case of
LC-UV, this was the chromatographic spectra at 280 nm (which includes multiple compounds with
chromophores not quantified in the LC-ESI-MS/MS method). The GC-MS spectra were used to study
the variability of volatile compounds in Lycium. Using the PCA from both these analytical methods, it
could be ascertained whether the L. barbarum and L. chinense samples separate into two distinct groups
in PCA analysis.
Data processing and statistical analysis was performed using the “R” statistical computing
package [44] and the add-on package “msProcess” [45]. This enabled chromatogram modification
by removal of instrumental noise, peak retention time variation between samples, baseline drift, and
identification of peaks thereby minimising sample variation due to instrumental factors. Extract
chromatograms were pre-processed, peaks were identified in each chromatogram and then aligned to
remove small variations in peak retention times between chromatograms. The chromatograms were
then normalized and binned. Whenever a peak was detected in any chromatogram, the amplitude
at that retention time was measured across all chromatograms in order to build a matrix of peak
amplitudes. One the dataset was constructed it was used to generate a “R.data” file which was then
used to create the PCA plots for the LC-UV and GC-MS chromatographic spectra.
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3. Results and Discussion
3.1. Chromatographic Data and Recoveries
A representative MS chromatogram for the method validation sample LB7 is shown in Figure 1.
Good recoveries (90.8%–109.5%) were obtained for the analytes of interest at all the spiking levels
as shown in Table 5. The 50% spike level showed slightly lower recoveries than the 100% and 200%
spiking levels. This is likely due to constant loss of the analyte due to the absorption onto glassware
surfaces. The average recovery RSD values are <10% for all the analytes.
3.2. Precision and MS Identity Confirmation
The analyte precisions of quantitation are shown in Table 6. The precision data shown in the table is
the overall method precision of n = 7 extractions of validation sample LB7 with each extraction injected
in triplicate. The two main contributors to method precision are the instrumental SD and the extraction
process SD, which primarily arises from errors in weighing, transferring and volume adjustment.
The method precision encompasses both the instrumental and extraction process SD and if the two
main sources of error were monitored independently, the instrumental error contributes approximately
one third to overall SD. The MS identity confirmation data is shown in Table 7. Most results are well
within the tolerances described by the guidelines set out in the European Commission Directorate for
Agricultural guidelines [43] except for m/z 93 of chlorogenic acid where identity confirmation fails by
1% where the required tolerance is ± 25% but ± 26% was obtained. Identity confirmation also fails for
caffeic acid which had only m/z 135 product ion for identity confirmation where two ions are required.
The calibration curves for all the analytes show good linearity with R2 > 0.999.
3.3. Analyte Concentrations and Fold Variation
The concentrations of the monitored analytes in twelve Lycium samples are shown in Table 8.
The seven bio-actives are present in both the L. barbarum and L. chinense samples except for caffeic acid
in the L. barbarum samples LB2 and LB4 and chlorogenic acid in LB2. High concentration components
such as rutin and coumaric acid show low fold variation at 3.1 and 1.8 respectively. Scopoletin had the
highest fold variation at 7.8 but this is due to its low concentration across the samples. This shows that
the L. barbarum and L. chinense samples are not chemically divergent, at least in the composition of
major bio-actives that have a role in their known pharmacological activity. Though the variation in
chemical composition is significant, it is lower than many other TCM herbs reported.
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Figure 1. Representative LC-ESI-MS/MS chromatogram of the extract of sample LB7 containing (1) Rutin, (2) Narcissin, (3) Nictoflorin, (4) Coumaric acid, (5) Scopoletin,
(6) Caffeic acid and (7) Chlorogenic acid.
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Recovery % RSD % Recovery % RSD % Recovery % RSD % Average Recovery b % RSD %
Rutin 93.1 3.7 90.2 7.9 89.1 8.6 90.8 6.7
Narcissin 105.6 3.4 101.7 1.7 100.5 2.5 102.6 2.8
Nictoflorin 92.2 3.8 94.5 2.9 95.2 2.5 93.9 3.1
Coumaric acid 98.4 7.5 88.6 9.3 102.0 3.8 96.3 6.8
Scopoletin 89.6 7.0 95.3 5.5 91.2 3.3 92.0 5.3
Caffeic acid 89.9 7.1 110.8 9.5 113.7 4.2 104.8 1.9
Chlorogenic acid 101 9.2 112.8 8.2 114.3 7.4 109.4 4.5
a: % Recovery ±% RSD calculated from n = 7 extractions and injected in triplicate. b: Average recovery of all three spiking levels ±% RSD. c: LOD was 0.005 mg/g. d: LOD was 0.003 mg/g.





LOD (mg/g) b LOQ (mg/g) c
Amount (mg/g) (±% RSD) RT (min) (±% RSD)
Rutin 0.9992 57.0-1140.0 34.8 (4.3) 9.37 (0.02) 0.42 1.4
Narcissin 0.9995 3.0-60.0 1.65 (2.8) 10.30 (0.01) 0.13 0.4
Nictoflorin 0.9994 0.6-11.6 0.77 (5.9) 10.20 (0.01) 0.14 0.47
Coumaric acid 0.9991 4.5-89.4 10.3 (6.9) 8.30 (0.02) 0.25 0.84
Scopoletin 0.9995 0.9-17.4 1.68 (4.3) 7.75 (0.03) 0.06 0.20
Caffeic acid 0.9995 0.1-1.6 0.11 (9.3) 6.35 (0.01) 0.04 0.12
Chlorogenic acid 0.9991 2.0-39.6 4.19 (5.9) 5.21 (0.01) 0.74 2.47
a: Average and RSD calculated from n = 7 extraction replicates injected in triplicate. b: Limit of detection (LOD) is three times the standard deviation (SD) for each analyte in LB7. c: Limit
of detection (LOQ) is ten times the standard deviation (SD) for each analyte in LB7.
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Table 7. Identity confirmation of the analytes.
Analyte
Relative Intensity Tolerances
m/z Standard Sample Relative Difference(±%) a
Permitted
Tolerance (±%) b Pass/Fail
Rutin
300 100 100 - 20 Pass
271 61 60 1.6 20 Pass
255 31 30 3.2 25 Pass
Narcissin
315 100 100 - 20 Pass
299 61 53 14 20 Pass
Nictoflorin
284 100 100 - 25 Pass
255 86 73 16 25 Pass
Coumaric
acid
120 100 100 - 25 Pass
93 29 28 3.5 25 Pass
Scopoletin
176 100 100 - 25 Pass
103 40 36 10 25 Pass
Caffeic acid 135 100 100 - 25 Pass
Chlorogenic
acid
191 100 100 - 25 Pass
93 50 37 26 25 Fail
a: Relative difference = [Intensity of sample—intensity of pure standard)/(intensity of pure standard)] × 100. b:
Maximum permitted tolerance from the European Commission Directorate for Agricultural guidelines [43].
Table 8. Concentrations of target analytes.
Analyte Concentrations in Sample (mg/g) (±% RSD) a









LB1 16.1 (9.3) 0.37 (3.0) 0.37 (8.5) 6.84 (4.5) 0.77 (6.7) 0.18 (3.8) 3.71 (5.4) 28.4
LB2 43.1 (8.5) 0.56 (4.8) 0.26 (1.9) 10.3 (7.0) 0.33 (9.0) <LOD <LOD 54.6
LB3 19.5 (3.3) 0.94 (7.5) 0.43 (4.9) 10.6 (4.1) 1.59 (3.8) 0.08 (9.4) 1.44 (6.6) 34.4
LB4 19.1 (3.8) 1.23 (6.8) 0.58 (7.8) 10.2 (5.3) 1.32 (6.9) <LOD 1.11 (5.4) 33.5
LB5 48.2 (6.2) 1.46 (5.2) 0.7 (7.8) 12.1 (5.7) 0.78 (6.7) 0.15 (7.1) 3.71 (5.3) 67.3
LB6 23.1 (2.8) 0.62 (6.5) 0.41 (5.8) 11.2 (4.1) 1.19 (6.0) 0.24 (7.0) 4.12 (5.8) 40.7
LB7 c 34.8 (4.3) 1.65 (2.8) 0.77 (5.9) 10.3 (6.9) 1.68 (4.3) 0.11 (9.3) 4.19 (5.9) 53.4
LB8 49.2 (3.3) 1.43 (6.6) 0.67 (4.6) 12.2 (5.9) 2.17 (6.9) 0.15 (7.0) 7.15 (9.0) 72.9
LC1 25.3 (2.5) 1.23 (4.4) 0.43 (8.0) 9.78 (5.8) 2.59 (6.4) 0.09 (6.1) 2.91 (8.3) 42.1
LC2 21.5 (3.6) 0.98 (2.6) 0.51 (3.7) 10.2 (5.6) 1.60 (5.5) 0.16 (4.3) 4.24 (7.2) 39.2
LC3 35.1 (6.7) 1.11 (3.5) 0.44 (3.6) 8.61 (7.1) 2.36 (5.1) 0.32 (6.4) 9.12 (7.3) 57.0
LC4 33.1 (4.0) 1.25 (3.4) 0.63 (4.9) 10.2 (7.0) 2.61 (4.7) 0.18 (6.7) 5.17 (5.3) 53.1
Mean
(mg/g) 30.7 1.07 0.52 10.2 1.58 0.17 4.26 48.1
Fold
variation b 3.1 3.9 6.0 1.8 7.8 4.3 7.3 N/A
a: Average calculated from n = 7 replicates ± % RSD. b: Fold variation = (highest concentration)/(lowest
concentration), (<LOD values omitted from this calculation). c: Analytical method validation performed on
this sample. d: LB = L. barbarum, LC = L. chinense.
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3.4. PCA Analysis
PCA analysis of Lycium was performed using LC-UV chromatograms visualized at 280 nm. At this
wavelength, a satisfactory number of peaks is observed—at shorter wavelengths, many peaks are
observed because most substances absorb in the short UV (<220 nm) whereas at long wavelengths
(>350 nm), the chromatogram can be relatively featureless. LC-UV can detect volatile and non-volatile
compounds with a chromophore while GC-MS monitors the volatile compounds. The y-axis is the
Euclidean distance for principal component PC1, and the x-axis is the distance for the principal
component PC2. The closer the samples are in terms of Euclidean distance, the more similar they
are to each other. Since two different chemical monitoring techniques are used for comparison, the
qualitative phytochemical variability of Lycium is understood in greater depth.
The chromatograms are visually similar, suggesting that there is little chemical difference between
the L. barbarum and L. chinense samples at least among the monitored bio-actives. The LC-UV PCA
score plot in Figure 2 shows the L. barbarum and L. chinense samples grouped into two close clusters
with significant overlap indicating that their profiles are near indistinguishable.
Figure 2. LC-UV spectra PCA score plot for the L. barbarum and L. chinense samples.
As with the LC-UV chromatograms, the GC-MS chromatograms are visually similar for the L.
barbarum and L. chinense samples. The PCA score plot of the GC-MS chromatograms is shown in
Figure 3. The LC3 and LC4 samples are shown to be part of an outlier group. The presence of distinct
un-analyzed volatile compounds in these samples could be the reason they are appear as outliers.
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Figure 3. GC-MS spectra PCA score plot for the L. barbarum and L. chinense samples.
Based on the GC-MS PCA score plot, the LC1 and LC2 L. chinense samples more closely resemble
those of L. barbarum while the remaining L. chinense samples are phytochemically indistinguishable.
Outliers LC3 and LC4 could be due to natural variation and/or growth conditions and post-harvest
treatment. Nevertheless, the seven monitored bio-actives are still present in LC3 and LC4.
4. Conclusions
A simple and rapid 15.5 min LC-ESI-MS/MS method was developed and validated to monitor
seven bio-actives in Lycium samples of the barbarum and chinense varieties. Total concentration of the
monitored bio-actives could be used to describe herbal quality. It is probable that these two Lycium
berries, though labelled differently, are essentially the same and likely to give similar physiological
effects. Any variation in chemical composition likely arises from factors described previously rather
than species type. While there are archetypal L. barbarum and L. chinense plants there may be hybrids,
further blurring their distinction. Mislabeling is another consideration, though the minor price
difference between the two Lycium’s makes this occurrence more likely accidental than deliberate.
Author Contributions: Conceptualization, C.K. and M.J.; Methodology, C.K., S.L., J.H., S.S. (Shaun Sullivan),
H.S., and M.J.; Software, H.S., J.H., and M.J.; Validation, C.K., J.H., S.L. and M.J.; Formal analysis, H.S., D.P., S.S.
(Swastika Singh), J.H. and M.J.; Investigation, H.S., J.H. and M.J.; Resources, C.K., S.L., C.X. and M.J.; Data curation,
H.S., S.S. (Swastika Singh), J.H. and M.J.; Writing—original draft preparation, M.J. and H.S.; Writing—review and
editing, C.K., H.S. and M.J.; Visualization, H.S. and D.P.; Supervision, C.K. and S.L.; Project administration, S.L.,
C.K. and M.J.; Funding acquisition, M.J., C.X and C.K.
Funding: This research received no external funding.
Acknowledgments: This work is based on the PhD thesis of Mariam Jarouche who is the primary author of this
research article [46]. The research was supported by the National Institute of Complementary Medicine (NICM),
Western Sydney University. We would also like to thank the Wentworth Institute for their support.
Plants 2019, 8, 604 15 of 17
Conflicts of Interest: The authors declare no conflict of interest regarding the publication.
Data Availability Statement: The chromatographic files used for PCA analysis and the recovery calculation files
used in method validation to support the findings of this study are available from the corresponding author
upon request.
References
1. Fukuda, T.; Yokoyama, J.; Ohashi, H. Phylogeny and biogeography of the genus Lycium (Solanaceae):
Inferences from chloroplast DNA sequences. Mol. Phylogenet Evol. 2001, 19, 246–258. [CrossRef] [PubMed]
2. Tilburt, J.C.; Kaptchuk, T.J. Herbal medicine research and global health: An ethical analysis. Bull. World
Health Organ. 2008, 86, 594–599. [CrossRef] [PubMed]
3. Amagase, H.; Farnsworth, N.R. A review of botanical characteristics, phytochemistry, clinical relevance in
efficacy and safety of Lycium barbarum fruit (Goji). Food Res. Int. 2011, 44, 1702–1717. [CrossRef]
4. Potterat, O. Goji (Lycium barbarum and L. chinense): Phytochemistry, Pharmacology and Safety in the
Perspective of Traditional Uses and Recent Popularity. Planta Med. 2010, 76, 7–19. [CrossRef] [PubMed]
5. Mocan, A.; Vlase, L.; Vodnar, D.C.; Bischin, C.; Hanganu, D.; Gheldiu, A.M.; Oprean, R.; Silaghi-Dumitrescu, R.;
Cris, an, G. Polyphenolic Content, Antioxidant and Antimicrobial Activities of Lycium barbarum L. and Lycium
chinense Mill Leaves. Molecules 2014, 19, 10056–10073. [CrossRef] [PubMed]
6. Zheng, G.Q.; Zheng, Z.Y.; Xu, X.; Hu, Z.H. Variation in fruit sugar composition of Lycium barbarum L. and
Lycium chinense Mill. of different regions and varieties. Biochem. Syst. Ecol. 2010, 38, 275–284. [CrossRef]
7. Lee, H.W.; Kim, Y.H.; Kim, Y.H.; Lee, G.H.; Lee, M.Y. Discrimination of Lycium chinense and Lycium barbarum
by taste pattern and betaine analysis. Int. J. Clin. Exp. Med. 2014, 7, 2053–2059.
8. Zhang, K.Y.B.; Leung, H.W.; Yeung, H.W.; Wong, R.N. Differentiation of Lycium barbarum from its related
Lycium species using random amplified polymorphic DNA. Planta Med. 2001, 67, 379–381. [CrossRef]
9. Sze, S.C.W.; Song, J.X.; Wong, R.N.S.; Feng, Y.B.; Ng, T.B.; Tong, Y.; Zhang, K.Y.B. Application of SCAR
(sequence characterized amplified region) analysis to authenticate Lycium barbarum (wolfberry) and its
adulterants. Biotechnol. Appl. Biochem. 2008, 5, 15–21. [CrossRef]
10. Monton, M.R.N.; Soga, T. Metabolome analysis by capillary electrophoresis–mass spectrometry. J. Chromatogr.
A. 2007, 1168, 237–246. [CrossRef]
11. Fiehn, O. Metabolomics—The link between genotypes and phenotypes. Plant. Mol. Biol. 2002, 48, 155–171.
[CrossRef] [PubMed]
12. Benchennouf, A.; Grigorakis, S.; Loupassaki, S.; Kokkalou, E. Phytochemical analysis and antioxidant activity
of Lycium barbarum (Goji) cultivated in Greece. Pharm. Biol. 2016, 55, 596–602. [CrossRef] [PubMed]
13. Magiera, S.; Zareba, M. Chromatographic Determination of Phenolic Acids and Flavonoids in Lycium
barbarum L. and Evaluation of Antioxidant Activity. Food Anal. Meth. 2015, 8, 2665–2674. [CrossRef]
14. Li, Y.; Di, R.; Hsu, W.; Huang, Y.Q.; Cheung, H.Y. Quality control of Lycium chinense and Lycium barbarum
cortex (Digupi) by HPLC using kukoamines as markers. Chin. Med. 2017, 12, 4. [CrossRef]
15. Chen, H.; Inbaraj, B.S.; Chen, B. Determination of Phenolic Acids and Flavonoids in Taraxacum formosanum
Kitam by Liquid Chromatography Tandem Mass Spectrometry Coupled with a Post-Column Derivatization
Technique. Int. J. Mol. Sci. 2012, 13, 260–285. [CrossRef]
16. Jarouche, M.; Suresh, H.; Low, M.; Lee, S.; Xu, C.; Khoo, C. Quality Control and Variability Assessment of an
Eight-Herb Formulation for Hypertension Using Method Validation and Statistical Analysis. Molecules 2019,
24, 1520. [CrossRef]
17. Therapeutic Goods Administration. Therapeutic Goods Administration Australian regulatory guidelines for
complementary medicines (ARGCM) Part B: Listed complementary medicines; Australian Government Department
of Health: Canaberra, Australia, 2015. Available online: https://www.tga.gov.au/book/argcmpart-b-listed-
complementary-medicines/ (accessed on 21 March 2018).
18. Bensoussan, A.; Lee, S.; Murray, C.; Bourchier, S.; van der Kooy, F.; Pearson, J.L.; Liu, J.; Chang, D.; Khoo, C.S.
Choosing chemical markers for quality assurance of complex herbal medicines: Development and application
of the herb MaRS criteria. Clin. Pharmacol. Ther. 2015, 97, 628–640. [CrossRef]
19. Guardia, T.; Rotelli, A.E.; Juarez, A.O.; Pelzer, L.E. Anti-inflammatory properties of plant flavonoids—Effects
of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Il Farmaco. 2001, 56, 683–687. [CrossRef]
Plants 2019, 8, 604 16 of 17
20. Qian, J.Y.; Liu, D.; Huang, A.G. The efficiency of flavonoids in polar extracts of Lycium chinense Mill fruits as
free radical scavenger. Food Chem. 2004, 87, 283–288. [CrossRef]
21. Wen, C.C.; Chen, H.M.; Yang, N.S. Developing phytocompounds from medicinal plants as
immunomodulators. In Advances in Botanical Research: Recent Trends in Medicinal Plant Research; Academic
Press: Cambridge, MA, USA, 2012; Volume 62, pp. 197–272. [CrossRef]
22. Marles, R.J.; Farnsworth, N.R. Antidiabetic plants and their active constituents. Phytomedicine 1995, 2,
137–189. [CrossRef]
23. Prince, P.S.M.; Priya, S. Preventive effects of rutin on lysosomal enzymes in isoproterenol induced cardio
toxic rats: Biochemical, histological and in vitro evidences. Eur. J. Pharmacol. 2010, 649, 229–235. [CrossRef]
[PubMed]
24. Kim, J.; Lee, K.W.; Lee, H.J. Polyphenols suppress and modulate inflammation: Possible roles in health and
disease. In Polyphenols in human health and disease, San Diego; Academic Press: Cambridge, MA, USA, 2014;
pp. 393–408.
25. Amagase, H.; Sun, B.; Borek, C. Lycium barbarum (goji) juice improves in vivo antioxidant biomarkers in
serum of healthy adults. Nutr. Res. 2009, 29, 19–25. [CrossRef] [PubMed]
26. Zhang, R.; Ah Kang, K.; Piao, M.J.; Kim, K.C.; Kim, A.D.; Chae, S.; Park, J.S.; Youn, U.J.; Hyun, J.W.
Cytoprotective effect of the fruits of Lycium chinense Miller against oxidative stress-induced hepatotoxicity.
J. Ethnopharmacol. 2010, 130, 299–306. [CrossRef] [PubMed]
27. Matkowski, A.; Jamiolkowska-Kozlowska, W.; Nawrot, I. Chinese medicinal herbs as source of antioxidant
compounds—Where tradition meets the future. Curr. Med. Chem. 2013, 20, 984–1004. [CrossRef]
28. Kim, S.Y.; Kim, H.P.; Huh, H.; Kim, Y.C. Antihepatotoxic zeaxanthins from the fruits of Lycium chinense. Arch.
Pharm Res. 1997, 20, 529–532. [CrossRef]
29. Le, K.; Chiu, F.; Ng, K. Identification and quantification of antioxidants in Fructus lycii. Food Chem. 2007, 105,
353–363. [CrossRef]
30. Oh, Y.C.; Cho, W.K.; Im, G.Y.; Jeong, Y.H.; Hwang, Y.H.; Liang, C.; Ma, J.Y. Anti-inflammatory effect of Lycium
fruit water extract in lipopolysaccharide-stimulated RAW 264.7 macrophage cells. Int. Immunopharmacol.
2012, 13, 181–189. [CrossRef]
31. Li, H.; Liu, X.; Yang, H.; Zhu, L. Effects of Lycium barbarum on the behavior, body weight and TNF-alpha
level of rat treated with binding. Wei sheng yan jiu—J. Hygiene Res. 2007, 36, 743–745.
32. Ho, Y.S.; Yu, M.S.; Lai, C.S.W.; So, K.F.; Yuen, W.H.; Chang, R.C.C. Characterizing the neuroprotective effects
of alkaline extract of Lycium barbarum on β-amyloid peptide neurotoxicity. Brain Res. 2007, 1158, 123–134.
[CrossRef]
33. Kiso, Y.; Suzuki, Y.; Watanabe, N.; Oshima, Y.; Hikino, H. Antihepatotoxic principles of Curcuma longa
rhizomes. Planta Med. 1983, 49, 185–187. [CrossRef]
34. Zhong, Y.; Shahidi, F.; Naczk, M. Phytochemicals and health benefits of Goji berries. Dried Fruits; Blackwell
Publishing Ltd.: Hoboken, NJ, USA, 2013; pp. 133–144.
35. Tang, W.M.; Chan, E.; Kwok, C.Y.; Lee, Y.K.; Wu, J.H.; Wan, C.W.; Chan, R.Y.K.; Yu, P.H.F.; Chan, W.W. A
review of the anticancer and immunomodulatory effects of Lycium barbarum fruit. Inflammopharmacology
2012, 20, 307–314. [CrossRef] [PubMed]
36. Kumar, S.; Pandey, A.K. Chemistry and biological activities of flavonoids: An overview. Sci. World J. 2013,
16. [CrossRef] [PubMed]
37. Wu, W.B.; Hung, D.K.; Chang, F.W.; Ong, E.T.; Chen, B.H. Anti-inflammatory and anti-angiogenic effects of
flavonoids isolated from Lycium barbarum Linnaeus on human umbilical vein endothelial cells. Food Funct.
2012, 3, 1068–1081. [CrossRef] [PubMed]
38. Okutan, H.; Ozcelik, N.; Yilmaz, H.R.; Uz, E. Effects of caffeic acid phenethyl ester on lipid peroxidation and
antioxidant enzymes in diabetic rat heart. Clin. Biochem. 2005, 38, 191–196. [CrossRef]
39. Luo, Q.; Cai, Y.; Yan, J.; Sun, M.; Corke, H. Hypoglycemic and hypolipidemic effects and antioxidant activity
of fruit extracts from Lycium barbarum. Life Sci. 2004, 76, 137–149. [CrossRef]
40. Yao, X.; Peng, Y.; Xu, L.J.; Li, L.; Wu, Q.L.; Xiao, P.G. Phytochemical and biological studies of Lycium
medicinal plants. Chem Biodivers. 2011, 8, 976–1010. [CrossRef]
41. Marques, V.; Farah, A. Chlorogenic acids and related compounds in medicinal plants and infusions. Food
Chem. 2009, 113, 1370–1376. [CrossRef]
Plants 2019, 8, 604 17 of 17
42. Chang, R.C.C.; So, K.F. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated
diseases. What do we know so far? Cell Mol. Neurobiol. 2008, 28, 643–652. [CrossRef]
43. European Commission Directorate. European Commission Directorate for Agriculture Commission decision
of August 12, 2002 implementing Council Directive 96/23/EC concerning the performance of analytical
methods and the interpretation of results. EUR-Lex. 2002. Available online: https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=CELEX%3A32002D0657/ (accessed on 14 September 2018).
44. R Project for Statistical Computing; Technische Universität, Wien: Wien, Austria, 2001.
45. R Development Core Team. R Foundation for Statistical Computing 2009; The R Project for Statistical Computing:
Union County, NJ, USA, 2009.
46. Jarouche, M. Study of the marketplace variation in the chemical profile of Qi Ju Di Huang Wan (Lycium,
Chrysanthemum and Rehmannia Formula). Ph.D. Thesis, Western Sydney University, Sydney, Australia,
2014. Available online: http://handle.uws.edu.au:8081/1959.7/uws:30079 (accessed on 12 December 2019).
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
